Experts update prostate cancer screening guidelines for men
Are you an American man between 50 and 69? You might want to get checked for prostate cancer, ACS says in reversal of…
Recent health headlines from STAT News.

A massive scientific collaboration has produced the most detailed map yet of the basal ganglia, a key brain region involved in an array of psychiatric and neurologic disorders.

Are you an American man between 50 and 69? You might want to get checked for prostate cancer, ACS says in reversal of…

Scores of doctors and scientists were elected last week. Will trust in science follow?

“Even as Kennedy and MAHA have cribbed from the Black activist playbook, they’ve actively undermined” Black Americans,…

“On day one, governors should know kindergarten vaccination rates by county,” write Mandy Cohen and Ellen Montz.

Drug companies seem to be looking for workarounds to protect their U.S. sales against Trump's "most-favored nations"…

“Children's food refusals come at a cost — one that few cash-strapped families can afford,” experts write.

Providers increasingly are suing employers, claiming they are responsible for out-of-network medical bills that…

Federal health officials granted blanket ethics waivers to USPSTF panel members, some of whom own pharma stocks and…

MDCalc, a medical reference tool site, is launching CrossCover, a tool meant to help clinicians trust the answers of…

BIO CEO: “Today’s biotech race is our generation’s Space Race.”

“Even a factually accurate health message can change behavior in ways that make people less healthy,” researchers write.

Texas, Georgia, and Wisconsin may expand their Medicaid programs when Democrats take power.

The theme of the American Heart Association meetings was "neutral" results. Yet no one wants to stop pursuing…

Novartis acknowledged seven instances of tumors being found in children who were treated with Zolgensma for spinal…

PhRMA spent an estimated $59 million on search advertising over a recent seven-year period to influence how Americans…

Three years ago, a trial for a sickle cell gene-editing therapy a decade in the making ended abruptly after the first…

Rasonque, Revolution Medicines' new pancreatic cancer drug, is off to one of the best oncology drug launches in history.

Massachusetts voters decisively shot down a ballot initiative that would have dismantled the state’s recreational…

Democrats win Senate control, and with it the power to push back on Trump’s health care moves.

Four big drugmakers allegedly paid tens of millions of dollars to middlemen to supply lifesaving drugs to Russian…

Inside the global fertility industry using women as "guinea pigs":

A STAT investigation found that Epic selectively withholds access to patient data, disadvantaging rival software…

“A few years ago, I froze my eggs — and the experience was anything but empowering,” writes physician Pooja Yerramilli.

STAT is looking to learn, from people with direct knowledge, how Epic's actions impact hospitals' technology choices.…

“It is dizzying to have a family clamoring for the MMR vaccine in one room while the room next door adamantly opposes…

Moderna and Merck's 'presidential' presentation, and other news from Day 2 of the European Society for Medical…

The Moderna-Merck cancer vaccine data reveal is days away. Here's what to expect.

U.S. is poised to issue a proposed rule that would subject outbound licensing deals with Chinese biotech companies to…

A KFF survey finds that rising healthcare costs are squeezing both employers and workers.

GSK has won FDA approval for its hepatitis B drug, which extended functional cures to far more patients than previous…

An immune drug from Roivant could be headed to a new market, after the company reported positive trials in the eye…

The median net price for newly launched medicines, when adjusted for inflation and manufacturer discounts, rose by 35%…

A jury awarded $6 million in damages to scientist David Sabatini, whose career imploded after he was accused by a much…

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical…

Rep. Jake Auchincloss (D-Mass.) has some advice for fellow lawmakers: unapologetically support the biotech industry.

White House planned shift of research funding from universities to industry risks creating a drought in basic…

A wave of clinical trials have begun to test the ability of GLP-1 weight loss drugs to quell various substance use…

Humana is swapping out private equity sponsors for its CenterWell Senior Primary Care clinics. Good bye, Welsh,…

Patient advocates and some experts are expressing growing alarm over the perceived risks of a Neurocrine Biosciences…

“Hordes of brilliant, graduate-degree-holding professionals in their 40s, 50s, and beyond act helpless at work,”…

Patient advocates and some experts are expressing growing alarm over the perceived risks of a rare disease drug sold…

“The legal and medical issues in the Christa Pike case are on a collision course,” writes bioethicist M. Sara Rosenthal.

Health As CDC redesigns annual health survey, it removes questions about disabilities The changes could result in…

Why have so many Americans lost trust in science? And what's the deal with a new gene-editing lawsuit? Find out on…

Health care companies dominate the MAHA Summit, and a look at Trump's watered down effort to lower Medicare drug prices.

In the Lab Judge blocks Trump administration plans to limit visa length for grad students, postdocs Proposed 4-year…

11, 2026 Pharmalot Columnist, Senior Writer Ed Silverman[email protected]Ed’s stories explore prescription drug…

Platinum chemotherapy's long-term effects, surprising heart failure drug failures, and more biotech news from The…

Naloxone and harm reduction measures may be helping to curb drug overdose deaths, a new report says.
WeSearch's declared handling of STAT News's content. Indexing, snippets, summaries, retrieval and training are separate questions — see the rights registry or read this source's machine-readable record.